Zenith Drugs (NSE:ZENITHDRUG) Common Stock: ₹171 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
35 GF Score
Price ₹49.25
! 8 Warning Signs
View Full Analysis

What is Zenith Drugs Common Stock?

Zenith Drugs NSE:ZENITHDRUG +0.61% 35 Common Stock is ₹171 Mil as of Mar. 2026. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 35/100. The stock has 8 warning signs investors should review.

Zenith Drugs's quarterly common stock stayed the same from Mar. 2025 (₹171 Mil) to Sep. 2025 (₹171 Mil) and stayed the same from Sep. 2025 (₹171 Mil) to Mar. 2026 (₹171 Mil).

Zenith Drugs's annual common stock stayed the same from Mar. 2024 (₹171 Mil) to Mar. 2025 (₹171 Mil) and stayed the same from Mar. 2025 (₹171 Mil) to Mar. 2026 (₹171 Mil).

Zenith Drugs Common Stock Historical Data

* Premium members only.

The historical data trend for Zenith Drugs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs Common Stock Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial 4.00 4.00 171.49 171.49 171.49

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only 171.49 0.00 171.49 171.49 171.49
NSE:ZENITHDRUG
35GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Drugs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹171 Mil mean?
Zenith Drugs (NSE:ZENITHDRUG) has a Common Stock of ₹171 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zenith Drugs and its competitors.
Is Zenith Drugs' Common Stock too high?
Zenith Drugs' current Common Stock is ₹171 Mil. Overall, Zenith Drugs has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' Common Stock compare to ZTS and UTHR?
Zenith Drugs' Common Stock of ₹171 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current Common Stock is ₹171 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current Common Stock of ₹171 Mil. The current Common Stock is ₹171 Mil. Zenith Drugs' overall GF Score™ is 35/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current Common Stock is ₹171 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
35GF Score

Get the complete analysis for NSE:ZENITHDRUG

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹49.25
Price